Donoghue Forlines LLC Zoetis Inc. Transaction History

Donoghue Forlines LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$155.97 - $200.09 $614,677 - $788,554	-3,941 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$181.39 - $234.03 $750,410 - $968,182	-4,137 Reduced 51.21%	3,941 $743,000
Q4 2021 Feb 11, 2022	BUY	$193.69 - $247.03 $1.56 Million - $2 Million	8,078 New	8,078 $1.97 Million
Q1 2018 May 03, 2018	SELL	$71.51 - $84.69 $2.59 Million - $3.07 Million	-36,201 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$63.24 - $72.8 $2.29 Million - $2.64 Million	36,201	36,201 $2.61 Million

1,921

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $84.9B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Donoghue Forlines LLC, based on Form 13F filings with the SEC.

Stay updated on Donoghue Forlines LLC with notifications on news.